Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.430
-0.040 (-1.62%)
At close: Jul 20, 2026, 4:00 PM EDT
2.440
+0.010 (0.41%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Grace Therapeutics Employees
Grace Therapeutics had 5 employees as of March 31, 2026. The number of employees decreased by 1 or -16.67% compared to the previous year.
Employees
5
Change (1Y)
-1
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,558,600
Market Cap
39.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | -1 | -16.67% |
| Mar 31, 2025 | 6 | 2 | 50.00% |
| Mar 31, 2024 | 4 | -28 | -87.50% |
| Mar 31, 2020 | 32 | 4 | 14.29% |
| Mar 31, 2019 | 28 | 17 | 154.55% |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PDS Biotechnology | 21 |
| Veru Inc. | 20 |
| RenovoRx | 17 |
| Lantern Pharma | 16 |
| CervoMed | 15 |
| Apollomics | 14 |
| Nutriband | 13 |
| Hyperion DeFi | 9 |
GRCE News
- 4 weeks ago - Grace Therapeutics reports FY26 EPS (47c) vs (79c) last year - TheFly
- 4 weeks ago - Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update - GlobeNewsWire
- 4 weeks ago - Grace Therapeutics Annual report: Q4 2026 - Filings
- 4 weeks ago - Grace Therapeutics Earnings release: Q4 2026 - Filings
- 4 weeks ago - Grace Therapeutics Slides: Corporate presentation - Filings
- 3 months ago - Grace Therapeutics price target lowered to $4 from $11 at Craig-Hallum - TheFly
- 3 months ago - Grace Therapeutics price target lowered to $8 from $12 at TD Cowen - TheFly
- 3 months ago - Grace Therapeutics down 48% after receipt of CRL from FDA for GTx-104 - TheFly